Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
92.01
+3.64 (4.12%)
Aug 17, 2026, 4:00 PM EDT - Market closed

Inhibrx Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-138.18-140.061,688-241.36-115.33-
Depreciation & Amortization
2.212.482.291.191.23-
Other Amortization
3.32.442.074.9--
Loss (Gain) From Sale of Assets
0.030.010.0100.02-
Loss (Gain) on Equity Investments
---1.63--
Stock-Based Compensation
11.6811.1458.5224.8517.79-
Other Operating Activities
1.911.8-1,9970.131.62-
Change in Accounts Receivable
0.080.2-0.19-0.540.13-
Change in Accounts Payable
1.48-3.317.92.11-0.38-
Change in Unearned Revenue
----0.17-1.1-
Change in Other Net Operating Assets
-14.39-4.5134.3313.945.21-
Operating Cash Flow
-131.89-129.79-194.41-193.31-90.81-
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.03-2.6-4.59-0.69-
Sale of Property, Plant & Equipment
00----
Investing Cash Flow
-0.01-0.03-2.6-4.59-0.69-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-99.97----
Net Debt Issued (Repaid)
74.9999.97----
Issuance of Common Stock
3.681.6171.68202.32--
Other Financing Activities
--0.13--0.3691.5-
Financing Cash Flow
78.67101.4571.68201.9691.5-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-53.22-28.38-125.334.06--

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-131.9-129.83-197.01-197.9-91.5-
Free Cash Flow Growth
------
Free Cash Flow Margin
--9986.54%-98503.00%-10994.56%-6957.95%-
Free Cash Flow Per Share
-8.47-8.38-13.15-16.80-2.28-
Levered Free Cash Flow
-85.1-84.46-92.57-106.38-55.74-
Unlevered Free Cash Flow
-78.68-79.27-86.21-91.38-55.74-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
11.648.911.5126.72--
Cash Income Tax Paid
00000-
Change in Working Capital
-12.82-7.6152.0515.353.86-
SEC Filings: 10-K · 10-Q